PeerVoice Internal Medicine Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes
    28:53
  2. 2.
    "Novel Approaches to Personalized Patient Care in Still's Disease"
    58:11
  3. 3.
    An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?
    41:28
  4. 4.
    Living With Multidrug-Resistant HIV: What Clinicians Need to Know
    28:10
  5. 5.
    Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies
    15:40
  6. 6.
    The Holistic Care of Patients with T2DM: Going Beyond HbA1c
    23:07
  7. 7.
    Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action
    20:47
  8. 8.
    Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis
    18:12
  1. 9.
    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care
    25:47
  2. 10.
    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
    17:07
  3. 11.
    Clinical Developments in Managing Autoinflammatory Diseases
    30:22
  4. 12.
    Improving Outcomes in Non-Metastatic CRPC: Case by Case
    20:05
  5. 13.
    Acute Psychosis: When to Suspect Acute Hepatic Porphyria
    18:12
  6. 14.
    Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
    12:48
  7. 15.
    Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes
    31:27
  8. 16.
    Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
    44:02
  9. 17.
    Therapy for COVID-19: Management Strategies and Clinical Rationale
    29:48
  10. 18.
    ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels
    25:24
  11. 19.
    Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
    8:39
  12. 20.
    Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed
    59:57
  13. 21.
    Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
    8:52
  14. 22.
    Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
    49:02
  15. 23.
    Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?
    58:25
  16. 24.
    Relieving the Burden of Acne and Scarring: A Holistic Approach
    28:49
  17. 25.
    Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
    10:45
  18. 26.
    Going the Distance in HIV: Simplifying ART at Every Stage
    24:03
  19. 27.
    Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?
    26:47
  20. 28.
    If I'd Known Then What I Know Now: Recognising My First AHP Patient
    18:33
  21. 29.
    Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
    19:31
  22. 30.
    "Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
    23:25
  23. 31.
    Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
    8:44
  24. 32.
    Simplifying Screening for Immunodeficiencies: A Practical Strategy Using Calculated Serum Globulin
    28:13
  25. 33.
    Transforming the Treatment of Acute Hepatic Porphyria
    22:02
  26. 34.
    Easy to Treat vs Easy to Manage Patients With HCV: What’s the Difference?
    29:28
  27. 35.
    Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold
    58:49
  28. 36.
    Optimising Treatment Outcomes in SJIA and AOSD
    16:43
  29. 37.
    Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
    21:16
  30. 38.
    Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC
    29:24
  31. 39.
    Biologics and Beyond in Atopic Dermatitis: Emerging Targets and How They Work
    22:11
  32. 40.
    "Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"
    13:19
  33. 41.
    Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
    32:52
  34. 42.
    Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data
    40:45
  35. 43.
    Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know
    29:16
  36. 44.
    Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
    59:05
  37. 45.
    Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
    27:28
  38. 46.
    Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
    16:21
  39. 47.
    Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists
    18:48
  40. 48.
    Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists
    26:24
  41. 49.
    GP Empowerment: Eliminating HCV From the Front Line
    29:21
  42. 50.
    If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis
    19:48

Listen to PeerVoice Internal Medicine Audio now.

Listen to PeerVoice Internal Medicine Audio in full in the Spotify app